Target intelligence / Profile preview

Paracrine signaling pathways in skin wound microenvironment

Molecular classification
Other
01

Overview

Paracrine signaling pathways in the skin wound microenvironment represent the complex network of local intercellular communication required for successful tissue regeneration. This system involves the secretion of diverse signaling molecules, including growth factors (e.g., PDGF, TGF-beta, VEGF) and cytokines, by resident and recruited cells such as macrophages, fibroblasts, and keratinocytes (Werner & Grose, 2003, Physiological Reviews). These factors act on neighboring cells to coordinate the overlapping phases of inflammation, proliferation, and remodeling (Gurtner et al., 2008, Nature). Dysregulation of these pathways is a hallmark of chronic, non-healing wounds like diabetic foot ulcers, where a pro-inflammatory environment persists, or in pathological scarring where signaling remains overactive (Pastar et al., 2014, Advances in Wound Care). While not a single molecular target, this microenvironment contains numerous druggable components; for instance, Becaplermin is a recombinant PDGF that mimics endogenous paracrine signals to promote healing (Eming et al., 2014, Sci Transl Med). Therapeutic strategies often aim to restore the spatiotemporal balance of these signals to accelerate closure while minimizing the risk of fibrosis.

Other names
Intercellular signaling in wound healingSkin wound microenvironment signalingParacrine factors in wound repairWound healing signaling network
02

Mechanism of action

Modulation of growth factor receptors and cytokine signaling cascades to restore the physiological balance of the wound microenvironment and promote tissue repair (Werner & Grose, 2003).

03

Biological functions

Signal transductionCell proliferationImmune responseAngiogenesisTissue remodelingCell migration
04

Disease associations

InflammationChronic woundsDiabetic foot ulcerFibrosisHypertrophic scarringKeloid
05

Safety considerations

Risk of tissue fibrosis or keloid formationPotential for oncogenic transformation with sustained growth factor stimulationLocalized inflammation or hypersensitivity
06

Interacting drugs

Becaplermin

2 more in the full profile.

07

Biomarkers

Transforming growth factor beta 1 (TGF-beta1)Vascular endothelial growth factor (VEGF)Platelet-derived growth factor (PDGF)Matrix metalloproteinase-9 (MMP-9)Interleukin-6 (IL-6)

Beyond the preview

Go deeper on Paracrine signaling pathways in skin wound microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine signaling pathways in skin wound microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call